104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain,
Saved in:
Main Authors: | Pereyra-Rodriguez,Jose Juan, Dominguez-Cruz,Javier, Armario-Hita,Jose Carlos, Ruiz-Villaverde,Ricardo |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Dermatologia
2021
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000600787 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
by: Giavina-Bianchi,Mara, et al.
Published: (2021) -
Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis,
by: Chello,Camilla, et al.
Published: (2021) -
Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
by: Giavina-Bianchi,Mara Huffenbaecher, et al.
Published: (2019) -
Real long-term data of dupilumab in atopic dermatitis
by: Briceño-Casado,MP, et al.
Published: (2020) -
Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis,
by: Maiolini,Viviane Maria, et al.
Published: (2021)